Selective prognostic impact of serum α-fetoprotein level in patients with hepatocellular carcinoma: Analysis of 543 patients in a single center

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 543-550

  Huo, Teh Ia ^a   Huang, Yi Hsiang ^a   Lui, Wing Yiu ^a   Wu, Jaw Ching ^a   Lee, Pui Ching ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; BLOOD; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TIME;

AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 3242803046     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.543     Document Type: Article

References (40)

1. Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P and Kerr DJ: Hepatocellular carcinoma. Ann Oncol 12: 161-172, 2001. (Pubitemid 32223862)
2. Bruix J and Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35: 519-524, 2002. (Pubitemid 34183954)
3. El-Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750, 1999. (Pubitemid 29114292)
4. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K and Kawamura E: Prognostic factors after hepatectomy for hepatocellular carcinoma: a univariate and multivariate analysis. Cancer 65: 1104-1110, 1990. (Pubitemid 20072042)
5. Kawasaki S, Makuuchi M, Miyagawa S, Kakazu T, Hayashi K, Kasai H, Miwa S, Hui AM and Nishimaki K: Results of hepatic resection for hepatocellular carcinoma. World J Surg 19: 31-34, 1995.
6. Jwo SC, Chiu JH, Chau GY, Loong CC and Lui WY: Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 16: 1367-1371, 1992.
7. Nagasue N, Uchida M, Makino Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T and Yukaya H: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105: 488-494, 1993. (Pubitemid 23213535)
8. Izumi R, Shimizu K, Li T, Yagi M, Matsui O, Nonomura A and Miyazaki I: Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106: 720-727, 1994. (Pubitemid 24064340)
9. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U and Herfarth C: Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 227: 424-432, 1998. (Pubitemid 28131024)
10. Esquivel CO, Keeffe EB, Garcia G, Imperial JC, Millan MT, Monge H and So SK: Resection versus transplantation for hepatocellular carcinoma. J Gastroenterol Hepatol 14: S37-S41, 1999. (Pubitemid 29281864)
11. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, Wenger JJ, Boissel P, Bigard MA and Doffoel M: Transcatheter oily chemoembolization for hepatocellular carcinoma: a 4-year study of 127 French patients. Cancer 74: 16-24, 1994. (Pubitemid 24187604)
12. Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Funaki T, Arima K, Yoshida S, Miyauchi Y and Kuriyama S: Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma. Int J Oncol 21: 841-846, 2002.
13. Huo TI, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY and Lee SD: Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol 14: 1648-1453, 2003.
14. Huang YH, Wu JC, Chau GY, Lui WY, King KL, Chiang JH, Yen SH, Sheng WY, Hou MC, Lu CL, Chang FY and Lee SD: Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 11: 315-321, 1999.
15. Hasegawa S, Yamasaki N, Hiwaki T, Sako K, Komorizono Y, Baba Y, Imamura Y, Kubozono O, Yoshida A and Arima T: Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 86: 1682-1690, 1999. (Pubitemid 29513036)
16. Shijo H, Okazaki M, Higashihara H, Koganemaru F and Okumura M: Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization. Am J Gastroenterol 87: 1154-1159, 1992.
17. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J and Bruix J: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739, 2002. (Pubitemid 34607087)
18. Simonetti RG, Liberati A, Angiolini C and Pagliaro L: Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 8: 117-136, 1997. (Pubitemid 27112878)
19. Orlando A, D'Antoni A, Camma C, Albanese M, Livraghi T, Torzilli G, Virdone R, Sciarrino E, Simonetti RG, Maringhini A, Pagliaro L and Cottone M: Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Am J Gastroenterol 95: 2921-2927, 2000.
20. Vilana R, Bruix J, Bru C, Ayuso C, Sole M and Rodes J: Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 16: 353-357, 1992.
21. Lencioni R, Bartolozzi C, Caramella D, Paolicchi A, Carrai M, Maltinti G, Capria A, Tafi A, Conte PF and Bevilacqua G: Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: analysis of prognostic factors in 105 Western patients. Cancer 76: 1737-1746, 1995.
22. Ohnishi K, Yoshioka H, Ito S and Fujiwara K: Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27: 67-72, 1998. (Pubitemid 28041536)
23. Okano H, Shiraki K, Inoue H, Kawakita T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K and Nakano T: Laparoscopic microwave coagulation therapy for small hepatocellular carcinoma on the liver surface. Oncol Rep 9: 1001-1004, 2002.
24. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY and Lee SD: Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective controlled study. Scand J Gastroenterol 38: 770-778, 2003.
25. The Cancer of the Liver Italian Program (CLIP) Investigators: A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28: 751-755, 1998.
26. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M and Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35: 421-430, 2001. (Pubitemid 32844200)
27. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R: Transection of the esophagus for bleeding oesophageal varices. Br J Surg 60: 646-964, 1973.
28. Edmonson HA and Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503, 1954.
29. Huo TI, Huang YH, Wu JC, Lee PC, Chang FY and Lee SD: Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scand J Gastroenterol 37: 350-355, 2002.
30. Bismuth H, Majno PE and Adam R: Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19: 311-322, 1999.
31. McPeake JR, O'Grady JG, Zaman S, B, Wight DG, Tan KC, Calne RY and Williams R: Liver transplantation for primary hepatocellular carcinoma: tumor size and number determined outcome. J Hepatol 18: 226-234, 1993. (Pubitemid 23246950)
32. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M and Makuuchi M: alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 35: 853-860, 2002. (Pubitemid 34258379)
33. Matsumura M, Niwa Y, Kato N, Shiratori Y, Omata M and Makuuchi M: Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 20: 1418-1425, 1994. (Pubitemid 24359050)
34. Matsumura M, Shiratori Y, Niwa Y, Tanaka T, Ogura K, Okudaira T, Imamura M, Okano K, Shiina S and Omata M: Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. J Hepatol 31: 332-339, 1999. (Pubitemid 29349761)
35. Nomura F, Ohnishi K and Tanabe Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Cancer 64: 1700-1707, 1989. (Pubitemid 19251142)
36. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY and Wu CW: Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127: 603-608, 2000.
37. Nomura F, Ohnishi K, Honda M, Satomura Y, Nakai T and Okuda K: Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 70: 690-693, 1994. (Pubitemid 24305600)
38. Attali P, Prod'Homme S, Pelletier G, Papoz L, Ink O, Buffet C and Etienne JP: Prognostic factors in patients with hepatocellular carcinoma: attempts for the selection of patients with prolonged survival. Cancer 59: 2108-2111, 1987. (Pubitemid 17077799)
39. Chlebowski RT, Tong M, Weissman J, Block JB, Ramming KP, Weiner JM, Bateman JR and Chlebowski JS: Hepatocellular carcinoma: diagnostic and prognostic features in North American patients. Cancer 53: 2701-2706, 1984. (Pubitemid 14112905)
40. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L and Brennan M: Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169: 28-34, 1995.